Basilard Biotech

Basilard BioTech's Celletto™ technology is a superior, nonviral nanomechanical-based gene delivery tool for use in the cell and gene therapy markets.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded July 2019
  • Employees 4
  • Incorporation Type C-corp
  • Website basilardbiotech.com

Company Summary

Introducing Celletto™, Basilard BioTech’s superior, scalable nonviral gene delivery technology to enable the improvement of patients’ lives and expand access to transformative medicines. Celletto™ is a working (post-POC), 2nd gen. technology with a proprietary nanomechanical transfection platform supporting GMP-compliant workflows for clinical translation; superior transfection performance and enablement of a broad range of therapeutic payloads.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free